- 功能驱动的宏基因组学涉及根据基因的功能表达而不是序列相似性来识别基因，从而为了解环境样本中的新酶、生物活性化合物和代谢途径提供见解
- 市场主要受到制药、农业和生物技术领域对新型生物分子日益增长的需求的推动。生物技术以及测序技术的进步和生物信息学工具
- 北美预计将以 40.76% 的市场份额占据功能驱动型宏基因组学市场的主导地位，这得益于其先进的医疗保健基础设施、高额的研发投入以及领先的生物技术和制药公司在宏基因组技术创新方面的强大影响力
- 预计亚太地区将成为预测期内功能驱动宏基因组学市场增长最快的地区，市场份额将达到 25.2%，这得益于生物技术研究投资的增加、测序技术的进步以及个性化医疗和基于微生物组的应用需求的不断增长
- 试剂盒和试剂板块预计将占据市场主导地位，市场份额达61.98%，因为它们在测序样本制备中发挥着至关重要的作用。这些试剂盒是DNA/RNA提取、文库制备和其他关键流程不可或缺的一部分，确保获得高质量、准确的结果。研究、诊断和药物研发领域对快速高效的微生物分析的需求日益增长，进一步推动了该板块的增长。
Frequently Asked Questions
U.S. is expected to dominate the global function driven metagenomics market with a market share of 38.8%, particularly in the North America region. This dominance is attributed to its significant investments in genomic research, the presence of leading biotechnology firms, and increasing demand for microbiome-based diagnostics and therapies
North America dominates the function driven metagenomics market with a market share of estimated 40.76%, driven by its advanced healthcare infrastructure, high investments in research and development, and strong presence of leading biotechnology and pharmaceutical companies driving innovation in metagenomic technologies
India is expected to witness the highest CAGR in the function driven metagenomics market. This growth is driven by the increasing healthcare needs of a large population and expanding access to advanced metagenomics technologies
